Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CovationBio PDO, formerly known as DuPont Tate & Lyle BioProducts, is a leading producer of renewably sourced 1,3-propanediol (Bio-PDO). The company utilizes a proprietary fermentation process to convert plant-derived sugars into high-performance ingredients for a variety of industries. Its flagship products, Zemea and Susterra, serve as sustainable, petroleum-free alternatives to glycols in cosmetics, personal care, and pharmaceuticals. Zemea is specifically marketed as a high-purity humectant and solvent for the life sciences sector, while Susterra is used in industrial applications like polyurethanes and heat transfer fluids. Headquartered in Loudon, Tennessee, the company operates the world's largest aerobic fermentation plant dedicated to Bio-PDO production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DuPont Tate & Lyle BioProducts.